Allspring Global Investments Holdings LLC Increases Holdings in iShares Biotechnology ETF $IBB

Allspring Global Investments Holdings LLC increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 12.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,531 shares of the financial services provider’s stock after purchasing an additional 5,625 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.11% of iShares Biotechnology ETF worth $8,937,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Tudor Investment Corp ET AL acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $931,000. McElhenny Sheffield Capital Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $25,400,000. Assetmark Inc. lifted its stake in shares of iShares Biotechnology ETF by 150,979.6% during the fourth quarter. Assetmark Inc. now owns 74,029 shares of the financial services provider’s stock worth $12,494,000 after buying an additional 73,980 shares during the period. WorthPointe LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at $1,424,000. Finally, Brookstone Capital Management increased its position in shares of iShares Biotechnology ETF by 91.0% in the 4th quarter. Brookstone Capital Management now owns 12,035 shares of the financial services provider’s stock valued at $2,031,000 after acquiring an additional 5,735 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $187.00 on Thursday. The business has a fifty day moving average of $178.75 and a 200 day moving average of $173.81. iShares Biotechnology ETF has a 1 year low of $130.25 and a 1 year high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.